-
Novel approaches to understand the role of cAMP and co-signaling cascades in synaptic plasticity and brain disorders
https://braincanada.ca/funded-grants/novel-approaches-to-understand-the-role-of-camp-and-co-signaling-cascades-in-synaptic-plasticity-and-brain-disordersSynaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. Project Overview Synaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. It is widely believed that synaptic plasticity is...
-
Novel biological agents in the treatment of amyotrophic lateral sclerosis based on progranulin/granulin structure
https://braincanada.ca/funded-grants/novel-biological-agents-in-the-treatment-of-amyotrophic-lateral-sclerosis-based-on-progranulin-granulin-structureChallenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Project Overview Challenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Our challenge is to develop a biologic-therapy that slows,...
-
Novel biomarkers of SOD1 pathology in familial and sporadic ALS
https://braincanada.ca/funded-grants/novel-biomarkers-of-sod1-pathology-in-familial-and-sporadic-alsMutations in the SOD1 gene, leading to the misfolding and toxic aggregation of SOD1 protein, are the second leading cause of Familial Amyotrophic Lateral Sclerosis (FALS-SOD1) and emerging literature has detected misfolded SOD1 (mSOD1) in the cerebrospinal fluid (CSF) and post-mortem tissue of...
-
Novel blood and neuroimaging markers of Alzheimer’s disease and cerebral amyloid angiopathy
https://braincanada.ca/funded-grants/novel-blood-and-neuroimaging-markers-of-alzheimer-s-disease-and-cerebral-amyloid-angiopathyAs our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Project Overview As our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Dementia is defined as cognitive (i.e., thinking) problems that...
-
Novel Cellular and Molecular Mechanisms Regulating Synapse Dysfunction in Alzheimer’s Disease
https://braincanada.ca/funded-grants/novel-cellular-and-molecular-mechanisms-regulating-synapse-dysfunction-in-alzheimer-s-diseaseIn Alzheimer s disease (AD), critical synaptic connections between neurons disintegrate and cells die. Project Overview In Alzheimer s disease (AD), critical synaptic connections between neurons disintegrate and cells die. The brains of individuals with AD accumulate plaques of a protein fragment...
-
Novel collaborations could lead to more effective ways to treat patients with ALS
https://braincanada.ca/about/news-updates/novel-collaborations-could-lead-to-more-effective-ways-to-treat-patients-with-als“There is a whole ecosystem within the central nervous system. This research provides a direct link as to what could really be going on when neurons are overactivated. If we can figure out the basis of that, then we can target that process with therapeutics.” – Dr. Janice Robertson One of the first...
-
Novel digital and adaptive marker of word-finding difficulties for early detection of Alzheimer’s disease
https://braincanada.ca/funded-grants/novel-digital-and-adaptive-marker-of-word-finding-difficulties-for-early-detection-of-alzheimer-s-diseaseOver 64% of older adults without neurocognitive disorders report forgetting the names of objects when speaking. Project Overview Over 64% of older adults without neurocognitive disorders report forgetting the names of objects when speaking. These difficulties are commonly dismissed as typical...
-
Novel First-In-Class Melatonin MT2 Receptor Agonist for Neuropathic Pain: Investigational New Drug (IND) – Enabling Studies
https://braincanada.ca/funded-grants/novel-first-in-class-melatonin-mt2-receptor-agonist-for-neuropathic-pain-investigational-new-drug-ind-enabling-studiesNeuropathic pain is a chronic pain disorder resulting from damage to the nerves. Project Overview Neuropathic pain is a chronic pain disorder resulting from damage to the nerves. It may be due to cancer, diabetes or conditions like fibromyalgia. Neuropathic pain is often eased by antidepressant or...
-
Novel mechanisms regulating intraneuronal Tau clearance as potential targets for Alzheimer’s disease
https://braincanada.ca/funded-grants/novel-mechanisms-regulating-intraneuronal-tau-clearance-as-potential-targets-for-alzheimer-s-diseaseIn Alzheimer’s disease (AD), the accumulation of toxic Tau protein in neurons leads to the formation of neurofbillary tangles, cell death, and cognitive impairments. Project Overview In Alzheimer’s disease (AD), the accumulation of toxic Tau protein in neurons leads to the formation of...
-
Novel MRI biomarkers for monitoring disease progression in ALS
https://braincanada.ca/funded-grants/novel-mri-biomarkers-for-monitoring-disease-progression-in-alsFor this project Dr. Sanjay Kalra and his team aims to improve on current techniques to use magnetic resonance imaging (MRI) as a readily available way to examine if a potential new treatment is working to slow down progression of ALS. Project Overview For this project Dr. Sanjay Kalra and his team...